HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Drugs for Rare Diseases Sub-Report
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Drugs for Rare Diseases Sub-Report
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
HTA
All the posts published.
The End of Clinical Summaries?
April 4, 2022
-
Market Access News
-
No comments
-
Posted by
MORSE
Read More →
Read More →
Career Opportunity at MORSE for Oncology HTA Consultant
October 4, 2021
-
Careers
,
What's New
-
Posted by
MORSE
We are seeking an individual with similar values, a passion for learning and an interest in making a meaningful contribution to consulting projects and our overall… Read More →
Read More →
MORSE Strengthens Public Payer Expertise
September 7, 2021
-
Market Access News
,
What's New
-
Posted by
MORSE
Read More →
Read More →
New INESSS Evaluation Fee Schedule
June 2, 2021
-
Market Access News
,
Publications
-
Posted by
Patrick Manfred
Read More →
Read More →
MORSE Consulting Releases 2021 Edition of the Canadian Reimbursement and Forecasting Timelines Report
May 4, 2021
-
Market Access News
,
Publications
,
What's New
-
Posted by
MORSE
Read More →
Read More →
CAHR Market Access 201 Conference Update – November 2020
December 1, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
MORSE Consulting Bolsters Private Payer Expertise
September 9, 2020
-
Market Access News
,
What's New
-
Posted by
MORSE
Read More →
Read More →
CADTH Pharmaceutical Reviews Update, Issue 16
July 10, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
CADTH Business Plan 2020-2021 Insights
May 12, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Summary of CADTH Pharmaceutical Reviews Update – Issue 15
May 6, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
April 2020 Update to The Canadian Reimbursement Trends & Timelines Report – Now Available
April 27, 2020
-
Market Access News
,
Publications
,
What's New
-
Posted by
MORSE
Read More →
Read More →
MORSE Consulting Strengthens HTA Strategy and Payer Expertise
February 18, 2020
-
Market Access News
,
What's New
-
Posted by
MORSE
Read More →
Read More →
Summary of the CADTH Drug Portfolio Information Session November 2019
December 2, 2019
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Update on the CanREValue Collaboration
November 12, 2019
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
NEW Canadian Reimbursement Trends and Timelines Report – now available!
September 18, 2019
-
Market Access News
,
Publications
,
What's New
-
Posted by
MORSE
Read More →
Read More →
Older posts
HTA - Info and details on - MORSE Consulting Inc.